» Articles » PMID: 32686767

Single-cell Transcriptomics Reveals Regulators Underlying Immune Cell Diversity and Immune Subtypes Associated with Prognosis in Nasopharyngeal Carcinoma

Abstract

Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with extremely skewed ethnic and geographic distributions. Increasing evidence indicates that targeting the tumor microenvironment (TME) represents a promising therapeutic approach in NPC, highlighting an urgent need to deepen the understanding of the complex NPC TME. Here, we generated single-cell transcriptome profiles for 7581 malignant cells and 40,285 immune cells from fifteen primary NPC tumors and one normal sample. We revealed malignant signatures capturing intratumoral transcriptional heterogeneity and predicting aggressiveness of malignant cells. Diverse immune cell subtypes were identified, including novel subtypes such as CLEC9A dendritic cells (DCs). We further revealed transcriptional regulators underlying immune cell diversity, and cell-cell interaction analyses highlighted promising immunotherapeutic targets in NPC. Moreover, we established the immune subtype-specific signatures, and demonstrated that the signatures of macrophages, plasmacytoid dendritic cells (pDCs), CLEC9A DCs, natural killer (NK) cells, and plasma cells were significantly associated with improved survival outcomes in NPC. Taken together, our findings represent a unique resource providing in-depth insights into the cellular heterogeneity of NPC TME and highlight potential biomarkers for anticancer treatment and risk stratification, laying a new foundation for precision therapies in NPC.

Citing Articles

Transcriptomic profiling reveals mechanism, therapeutic potential, and prognostic value of cancer stemness characteristic in nasopharyngeal carcinoma.

Chen J, Shen R, Zhu J, Wang Y, Fu L, Chen Y Funct Integr Genomics. 2025; 25(1):56.

PMID: 40053129 DOI: 10.1007/s10142-025-01561-w.


Single-cell and spatial transcriptome profiling reveal CTHRC1+ fibroblasts promote EMT through WNT5A signaling in colorectal cancer.

Lu Y, Chen Y, Wang Z, Shen H, Xu L, Huang C J Transl Med. 2025; 23(1):282.

PMID: 40050872 PMC: 11884118. DOI: 10.1186/s12967-025-06236-5.


Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors.

Diao J, Wei Z, Pei Y, Ge J, Qing Y, Wei Y Cancer Immunol Immunother. 2025; 74(4):129.

PMID: 40024914 PMC: 11872814. DOI: 10.1007/s00262-024-03885-1.


Single-cell Analysis Highlights Anti-apoptotic Subpopulation Promoting Malignant Progression and Predicting Prognosis in Bladder Cancer.

Chen L, Hao Y, Zhai T, Yang F, Chen S, Lin X Cancer Inform. 2025; 24:11769351251323569.

PMID: 40018511 PMC: 11866393. DOI: 10.1177/11769351251323569.


A Novel Inflammation-Marker-Based Prognostic Model for Advanced Pulmonary Lymphoepithelioma-Like Carcinoma.

Chen X, Liu T, Mo S, Yang Y, Chen X, Hong S J Inflamm Res. 2025; 18:2433-2445.

PMID: 40008083 PMC: 11859127. DOI: 10.2147/JIR.S502286.


References
1.
Zheng H, Dai W, Cheung A, Ko J, Kan R, Wong B . Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. Proc Natl Acad Sci U S A. 2016; 113(40):11283-11288. PMC: 5056105. DOI: 10.1073/pnas.1607606113. View

2.
Oestreich K, Yoon H, Ahmed R, Boss J . NFATc1 regulates PD-1 expression upon T cell activation. J Immunol. 2008; 181(7):4832-9. PMC: 2645436. DOI: 10.4049/jimmunol.181.7.4832. View

3.
Fang W, Yang Y, Ma Y, Hong S, Lin L, He X . Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials. Lancet Oncol. 2018; 19(10):1338-1350. DOI: 10.1016/S1470-2045(18)30495-9. View

4.
Haldar M, Kohyama M, So A, Kc W, Wu X, Briseno C . Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell. 2014; 156(6):1223-1234. PMC: 4010949. DOI: 10.1016/j.cell.2014.01.069. View

5.
Chittezhath M, Dhillon M, Lim J, Laoui D, Shalova I, Teo Y . Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression. Immunity. 2014; 41(5):815-29. DOI: 10.1016/j.immuni.2014.09.014. View